Evidence map›Paper›PMID 26501252›Full record

ReviewMolecules (Basel, Switzerland)2015

Melatonin as a Potent and Inducible Endogenous Antioxidant: Synthesis and Metabolism.

Dun-Xian Tan, Lucien C Manchester, Eduardo Esteban-Zubero, Zhou Zhou, Russel J Reiter

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 302 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
302citing papers in PubMed, 6 pooled it
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

302 citing papers in PubMed, 6 syntheses or guidelines pooled it, 696 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Gut microbes · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

242 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dun-Xian TanDepartment of Cellular and Structural Biology, Health Science Center, University of Texas, San Antonio, TX 78229, USA. tan@uthscsa.edu.
Lucien C ManchesterDepartment of Cellular and Structural Biology, Health Science Center, University of Texas, San Antonio, TX 78229, USA. lmanchester@stmarytx.edu.
Eduardo Esteban-ZuberoDepartment of Cellular and Structural Biology, Health Science Center, University of Texas, San Antonio, TX 78229, USA. eezubero@gmail.com.
Zhou ZhouDepartment of Cellular and Structural Biology, Health Science Center, University of Texas, San Antonio, TX 78229, USA. LunaZhou00@163.com.
Russel J ReiterDepartment of Cellular and Structural Biology, Health Science Center, University of Texas, San Antonio, TX 78229, USA. reiter@uthscsa.edu.
The University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melatonin is a tryptophan-derived molecule with pleiotropic activities. It is present in almost all or all organisms. Its synthetic pathway depends on the species in which it is measured. For example, the tryptophan to melatonin pathway differs in plants and animals. It is speculated that the melatonin synthetic machinery in eukaryotes was inherited from bacteria as a result of endosymbiosis. However, melatonin's synthetic mechanisms in microorganisms are currently unknown. Melatonin metabolism is highly complex with these enzymatic processes having evolved from cytochrome C. In addition to its enzymatic degradation, melatonin is metabolized via pseudoenzymatic and free radical interactive processes. The metabolic products of these processes overlap and it is often difficult to determine which process is dominant. However, under oxidative stress, the free radical interactive pathway may be featured over the others. Because of the complexity of the melatonin degradative processes, it is expected that additional novel melatonin metabolites will be identified in future investigations. The original and primary function of melatonin in early life forms such as in unicellular organisms was as a free radical scavenger and antioxidant. During evolution, melatonin was selected as a signaling molecule to transduce the environmental photoperiodic information into an endocrine message in multicellular organisms and for other purposes as well. As an antioxidant, melatonin exhibits several unique features which differ from the classic antioxidants. These include its cascade reaction with free radicals and its capacity to be induced under moderate oxidative stress. These features make melatonin a potent endogenously-occurring antioxidant that protects organisms from catastrophic oxidative stress.

Indexed as

AnimalsAntioxidantsBiosynthetic PathwaysHumansMelatoninOxidative StressReactive Nitrogen SpeciesReactive Oxygen SpeciesAntioxidantsMelatoninReactive Nitrogen SpeciesReactive Oxygen Speciesantioxidantmelatoninmetabolismoxidative stressplantssynthesis

Identifiers

PMID26501252
PMCPMC6332205
OpenAlexW1962181495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.